CLASS II ONGOING Device recall · Reported 13 May 2026 · FDA Enforcement Report

Biofire Spotfire Respiratory/Sore Throat Panel recalled

BioFire Diagnostics is recalling Biofire Spotfire Respiratory/Sore Throat Panel, distributed nationwide in the US. The recall was initiated on 1 Apr 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot Number: 2215125/UDI: 00815381020390
Quantity recalled2400 pouches

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2081-2026
FDA event ID
98719
Recalling firm
BioFire Diagnostics, Salt Lake City, UT
Classification
Class II
Status
Ongoing
Recall initiated
1 Apr 2026
FDA classified
6 May 2026
Reported
13 May 2026
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Device Malfunction

Timeline

1 Apr 2026Recall initiated by company
6 May 2026Classified by FDA+35 days
13 May 2026Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Respiratory/sore throat panel test may result in false negative results and control failures.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Biofire Spotfire Respiratory/Sore Throat Panel REF: 423485

Where it was distributed

US Nationwide distribution in the states of MS, TX MN, VA.

Nationwide MinnesotaMississippiTexasVirginia

Questions about this recall

Is Biofire Spotfire Respiratory/Sore Throat Panel recalled?

Yes. BioFire Diagnostics recalled Biofire Spotfire Respiratory/Sore Throat Panel on 1 Apr 2026. The recall is Class II and its status is Ongoing. Recall number Z-2081-2026.

Why was it recalled?

Respiratory/sore throat panel test may result in false negative results and control failures.

Which lots are affected?

Lot Number: 2215125/UDI: 00815381020390

Where was it sold?

US Nationwide distribution in the states of MS, TX MN, VA.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from BioFire Diagnostics

All 44

Other CPAP & Ventilators recalls

All 552